Evidence map›Paper›PMID 33479120›Full record

ArticleScience (New York, N.Y.)2021

Noncanonical scaffolding of G

Jeffrey S Smith, Thomas F Pack, Asuka Inoue, Claudia Lee, Kevin Zheng, Issac Choi, Dylan S Eiger, Anmol Warman, Xinyu Xiong, Zhiyuan Ma and 8 more

Open access · greenAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 112 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Luciferase complementation for cellular assays beyond protein-protein interactions.Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2025
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 3 institutions in 2 countries.

Jeffrey S Smith *Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0003-2840-2899
Thomas F Pack *Department of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0002-1240-8324
Asuka InoueDepartment of Pharmaceutical Sciences, Tohoku University, Japan.ORCID https://orcid.org/0000-0003-0805-4049
Claudia LeeDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0003-1952-3859
Kevin ZhengDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0002-1437-2820
Issac ChoiDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Dylan S EigerDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0001-9572-6282
Anmol WarmanDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0001-5564-6747
Xinyu XiongDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0002-9803-8503
Zhiyuan MaDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0002-0381-7804
Gayathri ViswanathanDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0001-7395-919X
Ian M LevitanDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.
Lauren K RochelleDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0002-0669-1362
Dean P StausDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.
Joshua C SnyderDepartment of Cell Biology, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0002-9787-3371
Alem W KahsaiDepartment of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0001-9272-4484
Marc G CaronDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA.ORCID https://orcid.org/0000-0003-0172-2710
Sudarshan RajagopalDepartment of Medicine, Duke University Medical Center, Durham, NC 27710, USA. sudarshan.rajagopal@duke.edu.ORCID https://orcid.org/0000-0002-3443-5040
Duke Medical Center · USDuke University · USTohoku University · JP

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
Akt/GSK-3 Signaling Cascade and the Actions of DopamineR37MH073853 · NIMH · DUKE UNIVERSITY · PI CARON, MARC G. · 2011 to 2020
$6.4M
Biasing CXCR3 Signaling to Modulate the Inflammatory ResponseR01GM122798 · NIGMS · DUKE UNIVERSITY · PI RAJAGOPAL, SUDARSHAN · 2017 to 2025
$3.2M
Supplemental Funds for K22 Establishing the molecular and cellular mechanisms of Lgr5 signaling for controlling cancer stem cell behaviorK22CA212058 · NCI · DUKE UNIVERSITY · PI SNYDER, JOSHUA CLAIR · 2017 to 2020
$622k
Noncanonical Receptor Signaling in Pulmonary Arterial HypertensionK08HL114643 · NHLBI · DUKE UNIVERSITY · PI RAJAGOPAL, SUDARSHAN K · 2013 to 2017
$607k
Dissecting the Distinct Arrestin Signaling Capabilities of the Short and Long Dopamine D2 Receptors as a Paradigm for Psychostimulant Addiction TreatmentF31DA041160 · NIDA · DUKE UNIVERSITY · PI PACK, THOMAS FRANKLIN · 2016 to 2017
$67k
NCI NIH HHS K22 CA212058NHLBI NIH HHS K08 HL114643NIDA NIH HHS F31 DA041160NIGMS NIH HHS R01 GM122798NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM145449NIMH NIH HHS R37 MH073853
6 · The paper itself

Abstract

Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) are common drug targets and canonically couple to specific G

Indexed as

beta-ArrestinsBioluminescence Resonance Energy Transfer TechniquesCell MovementExtracellular Signal-Regulated MAP KinasesGTP-Binding Protein alpha Subunits, Gi-GoHEK293 CellsHumansReceptors, G-Protein-CoupledSignal Transductionbeta-ArrestinsExtracellular Signal-Regulated MAP KinasesGTP-Binding Protein alpha Subunits, Gi-GoReceptors, G-Protein-Coupled

Identifiers

PMID33479120
PMCPMC8005335
OpenAlexW3125274977

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.